Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 20739887)

1.

PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.

Cenciarelli C, Marei HE, Zonfrillo M, Pierimarchi P, Paldino E, Casalbore P, Felsani A, Vescovi AL, Maira G, Mangiola A.

Mol Cancer. 2014 Nov 8;13:247. doi: 10.1186/1476-4598-13-247.

2.

IgE-based Immunotherapy of Cancer -A Comparative Oncology Approach.

Singer J, Jensen-Jarolim E.

J Carcinog Mutagen. 2014 May 31;5(3):1000176.

3.

Glioblastoma cancer stem cells: Biomarker and therapeutic advances.

Pointer KB, Clark PA, Zorniak M, Alrfaei BM, Kuo JS.

Neurochem Int. 2014 May;71:1-7. doi: 10.1016/j.neuint.2014.03.005. Epub 2014 Mar 19. Review.

4.

microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models.

Alrfaei BM, Vemuganti R, Kuo JS.

PLoS One. 2013 Nov 14;8(11):e80865. doi: 10.1371/journal.pone.0080865. eCollection 2013.

5.

Profiling and metaanalysis of epidermal keratinocytes responses to epidermal growth factor.

Blumenberg M.

BMC Genomics. 2013 Feb 8;14:85. doi: 10.1186/1471-2164-14-85.

6.

The dynamic nature of the kinome.

Graves LM, Duncan JS, Whittle MC, Johnson GL.

Biochem J. 2013 Feb 15;450(1):1-8. doi: 10.1042/BJ20121456. Review.

7.

Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.

Latasa MU, Salis F, Urtasun R, Garcia-Irigoyen O, Elizalde M, Uriarte I, Santamaria M, Feo F, Pascale RM, Prieto J, Berasain C, Avila MA.

PLoS One. 2012;7(12):e52711. doi: 10.1371/journal.pone.0052711. Epub 2012 Dec 20.

8.

Epidermal growth factor receptor: is it a feasible target for the treatment of osteosarcoma?

Lee JA, Ko Y, Kim DH, Lim JS, Kong CB, Cho WH, Jeon DG, Lee SY, Koh JS.

Cancer Res Treat. 2012 Sep;44(3):202-9. doi: 10.4143/crt.2012.44.3.202. Epub 2012 Sep 30.

9.

Neutralization of IL-8 prevents the induction of dermatologic adverse events associated with the inhibition of epidermal growth factor receptor.

Bangsgaard N, Houtkamp M, Schuurhuis DH, Parren PW, Baadsgaard O, Niessen HW, Skov L.

PLoS One. 2012;7(6):e39706. doi: 10.1371/journal.pone.0039706. Epub 2012 Jun 25.

10.

Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.

Clark PA, Iida M, Treisman DM, Kalluri H, Ezhilan S, Zorniak M, Wheeler DL, Kuo JS.

Neoplasia. 2012 May;14(5):420-8.

11.

Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue.

Hembrough T, Thyparambil S, Liao WL, Darfler MM, Abdo J, Bengali KM, Taylor P, Tong J, Lara-Guerra H, Waddell TK, Moran MF, Tsao MS, Krizman DB, Burrows J.

Clin Proteomics. 2012 May 3;9(1):5. doi: 10.1186/1559-0275-9-5.

12.

Alternative splicing in oncogenic kinases: from physiological functions to cancer.

Druillennec S, Dorard C, Eychène A.

J Nucleic Acids. 2012;2012:639062. doi: 10.1155/2012/639062. Epub 2011 Oct 5.

13.

Medullary thyroid carcinoma: molecular signaling pathways and emerging therapies.

Gómez K, Varghese J, Jiménez C.

J Thyroid Res. 2011;2011:815826. doi: 10.4061/2011/815826. Epub 2011 May 16.

14.

Pleomorphic liposarcoma: clinical observations and molecular variables.

Ghadimi MP, Liu P, Peng T, Bolshakov S, Young ED, Torres KE, Colombo C, Hoffman A, Broccoli D, Hornick JL, Lazar AJ, Pisters P, Pollock RE, Lev D.

Cancer. 2011 Dec 1;117(23):5359-69. doi: 10.1002/cncr.26195. Epub 2011 May 19.

15.

Wnt signaling and colon carcinogenesis: beyond APC.

Najdi R, Holcombe RF, Waterman ML.

J Carcinog. 2011 Mar 17;10:5. doi: 10.4103/1477-3163.78111.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk